Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02916927 · ClinicalTrials.gov registry record · Phase 4
Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department
A Phase 4 study, sponsored by Alameda Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT02916927 is a Phase 4 study that has completed, run by Alameda Health System. The registered enrollment target is 62 participants.
The verdict
NCT02916927, a Phase 4 study, has completed, sponsored by Alameda Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
Objective: The purpose of this study is to determine if administering ketamine as an intravenous (IV) infusion over 15 minutes, as compared to an IV push, will decrease adverse drug reactions without attenuating its analgesic effects. Study design: prospective, randomized, controlled, double-blind trial.
Interventions
- DRUG Ketamine IV Infusion
- DRUG Ketamine IV push
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02916927
The ClinicalTrials.gov registry entry for NCT02916927 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alameda Health System, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine IV Infusion is the first listed.
NCT02916927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02916927 about?
NCT02916927 is a clinical study titled "Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department". Objective: The purpose of this study is to determine if administering ketamine as an intravenous (IV) infusion over 15 minutes, as compared to an IV push, will decrease adverse drug reactions without attenuating its analgesic effects. Study design: prospective, randomized, controlled, double-blind ...
What is the current status of trial NCT02916927?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2016-09. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02916927?
The interventions under investigation include: Ketamine IV Infusion (DRUG), Ketamine IV push (DRUG).
Who is sponsoring clinical trial NCT02916927?
This trial is sponsored by Alameda Health System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.